Publication | Open Access
Regional differences in sorafenib‐treated patients with hepatocellular carcinoma: <scp>GIDEON</scp> observational study
50
Citations
7
References
2016
Year
Data from GIDEON highlight regional variations in the management of HCC and patient outcomes. Greater standardisation of management may help optimise outcomes for HCC patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1